2025-05-22 06:01:36 pm | Source: reuters
India`s Sun Pharma posts quarterly profit rise on strong demand for rare disease drugs
Sun Pharmaceutical, India's largest drugmaker by revenue, reported a rise in adjusted quarterly profit on Thursday, driven by strong domestic demand for its drugs to treat rare diseases.
The Mumbai-based firm's consolidated profit before exceptional items and tax rose 24% to 36.16 billion rupees ($420.7 million) in the three months ended March 31.
Disclaimer:
The content of this article is for informational purposes only and should not be considered financial or
investment advice. Investments in financial markets are subject to market risks, and past performance is
not indicative of future results. Readers are strongly advised to consult a licensed financial expert or
advisor for tailored advice before making any investment decisions. The data and information presented
in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the
content of this article for any current or future financial references.
To Read Complete Disclaimer Click Here
Latest News
Buy ICICI Prudential Life Insurance Company Ltd For ...
Best SUVs Under Rs15 Lakh in India: Top Choices for ...
Morning Brief ? July 16, 2026 by CareEdge Ratings
Hold Mangalore Refinery & Petrochemicals Ltd For Tar...
Smart Casual Dressing: The Perfect Balance Between C...
Happiness Science: The Habits That Can Help You Live...
Buy HDFC Life Insurance Company Ltd For Target Rs.76...
Women Entrepreneurs Transforming India
Accumulate Union Bank of India Ltd For Target Rs.190...
Banks Set for Double-Digit Profit Growth in Q1FY27 D...
